Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for postoperative behavioral changes in children after day surgery
ChiCTR2100048616Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative behavioral disturbance (PBD) (3 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Postoperative behavioral change. Started Feb 2021; status: completed.
02
Drugs
esketamine
03
Conditions
postoperative behavioral disturbance (PBD)
Beyond the preview
Go deeper on ChiCTR2100048616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048616.